- CSR Summary Not Available
- NCT00236639
- Primary Citation
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNutritional and Metabolic DiseasesEnrollment1293% FemaleN/A% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-OBES-002Data PartnerJohnson & JohnsonCondition StudiedObesityMean/Median Age (Years)N/A
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available